ArticleTheranostics2019
APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
Huarong Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
42 papers cite it
this papercites it
ArticleTheranostics2019
Huarong Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.